Dissolving peptide films are spreading in biohacking circles. The piece sorts out what's approved, what's being sold and what the science supports.
Recap by typeshit. Full story at The News & Observer.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A surgeon on social media says the FDA has received two death reports involving black-market retatrutide. No official FDA statement is linked.
Pooling six trials with 3,459 adults, researchers saw bigger drops in weight, HbA1c and blood pressure at the higher dose. They flag small liver enzyme rises to monitor.
A 2022 PLOS ONE study found 63.2% of people reported needle phobia. BioNxt is working on a sublingual semaglutide film, though such formats aren't FDA approved.
Loading…